Elsevier Author Services and Research Gold are often shortlisted together, and they are not competitors. Elsevier Author Services is a language and submission-readiness desk attached to one of the largest academic publishers: it edits, translates, formats, and screens manuscripts that authors have already written. Research Gold is a systematic review writing service whose methodologists perform the evidence synthesis itself. Placing them side by side on a feature table produces a misleading picture, because only one of the two ever touches the study design. The useful comparison is about what stage your project is in and which risks you are actually trying to remove.
Both vendors sell expertise to academic authors, both quote before starting, and both promise a manuscript that is closer to publishable than the one you sent. The similarity ends at the input each requires.
An editing desk requires a finished draft. Its value is realised in the gap between what you wrote and what a reader understands. A methodology firm requires only a research question. Its value is realised in the decisions made before writing begins: what gets searched, who screens it, how bias is judged, and whether pooling the results is defensible at all.
That difference in required input is the entire comparison. It also explains why authors sometimes feel a language edit did not solve their problem: the problem was upstream of the text.
Elsevier Author Services offers English language editing at tiered service levels, scientific translation, manuscript formatting to journal specifications, figure and graphic preparation, plagiarism screening, and author training resources. Pricing is published on a per-word basis with tiers that vary by depth of edit and speed of return.
The publisher relationship carries a real advantage at the formatting layer. Editors working inside the publisher's ecosystem handle its journals' house styles constantly, so submission-readiness for those titles is a genuine strength rather than a marketing claim.
What the service does not do is equally clear, and Elsevier does not claim otherwise: it does not design search strategies, does not screen citations, does not assess risk of bias, and does not run statistical synthesis.
The work an evidence synthesis needs before it can be written is a distinct discipline:
- Protocol design that fixes eligibility criteria and outcomes in advance, so decisions cannot drift to suit the results.
- Database-specific search strategies rather than one query reused everywhere, since MEDLINE, Embase, Cochrane CENTRAL, CINAHL, and Scopus each index differently.
- Dual-reviewer screening with a documented process for resolving disagreement.
- Structured data extraction that a reviewer or editor can audit line by line.
- Risk of bias assessment using the instrument matched to the design, meaning RoB 2, ROBINS-I, or QUADAS-2.
- Statistical synthesis, including the judgement of whether pooling is appropriate, plus heterogeneity and publication bias diagnostics.
- Certainty rating under GRADE, presented in a summary of findings table.
These are performed by methodologists and statisticians, not editors, which is the practical reason having the whole review handled for you and a language edit sit in different budget lines.
Answer these about your own project:
- Is the synthesis finished, or only the idea?
- Was the protocol fixed before screening started?
- Did two people screen each record?
- Has risk of bias been assessed with a named, validated tool?
- If you pooled results, can you produce the code that generated the estimate?
Every "no" is a methodology gap, and methodology gaps are invisible to an editing desk. Every "yes" alongside a clumsy manuscript is a language problem, which is exactly where Elsevier Author Services earns its fee. Authors deciding between an individual contractor and a firm for the first category will find our comparison of a freelancer against an established provider covers the trade-offs.
Per-word editing prices scale with the length of your document. Project-based methodology prices scale with the size of the evidence base, because the cost driver is the number of records screened, the number of studies extracted, and whether a statistical synthesis is in scope.
This is why a long manuscript can be inexpensive to edit and a short one expensive to produce. Research Gold publishes a starting price of $895, and how our project pricing is structured is set out tier by tier. Where pooling is appropriate, the scope of a meta-analysis carried out end to end is quoted on the same project basis rather than by word count.
The efficient order is methodology first, language second. Editing a manuscript before the analysis is settled means paying to polish sentences that are about to be rewritten when a sensitivity analysis changes an estimate.
A workable sequence is: settle the protocol, run the search and screening, complete extraction and bias assessment, finish the synthesis, produce the full manuscript, then send the finished file to a publisher editing desk for language and house-style alignment before submission. Authors working toward a clinical journal will find the same sequencing logic in our medical manuscript preparation guide.
Whichever vendor you choose, get these confirmed in the quotation rather than in conversation:
- The precise deliverable, named as a document.
- Whether the timeline starts on signature or on receipt of your draft.
- What counts as in-scope revision after delivery, and what triggers a new quotation.
- Who performs the work and what their background is in this specific area.
- What happens if a journal requests a change that was not in the original scope.
Vendors that answer these in writing tend to be the ones that behave predictably later. A quotation that leaves revision scope undefined is the single most common source of dispute in this market.
Research Gold is the option for authors who need the review performed rather than proofread. The deliverable is a complete manuscript with reproducible R or Stata code, a PRISMA 2020 flow diagram, and a GRADE certainty profile where meta-analysis is in scope. Authors who only need the language layer can use our in-house publication-ready academic editing, and those still comparing methodology providers can read our round-up of systematic review providers. To scope a project, send us your research question and a methodologist will assess the question and the evidence base with you.
- PRISMA 2020 statement: Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
- Cochrane Handbook for Systematic Reviews of Interventions, Version 6.5.
- GRADE Handbook (Guyatt G, et al.). gdt.gradepro.org
- Elsevier Author Services public website (services and pricing pages, accessed 2026).